Boston Scientific Corp (BSX)vsStandard Biotools Inc (LAB)
BSX
Boston Scientific Corp
$69.78
+2.39%
HEALTHCARE · Cap: $101.28B
LAB
Standard Biotools Inc
$0.96
+1.27%
HEALTHCARE · Cap: $379.85M
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 23425% more annual revenue ($20.07B vs $85.33M). BSX leads profitability with a 14.4% profit margin vs -87.8%. BSX earns a higher WallStSmart Score of 63/100 (C+).
BSX
Buy63
out of 100
Grade: C+
LAB
Avoid31
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+1.2%
Fair Value
$70.62
Current Price
$69.78
$0.84 discount
Intrinsic value data unavailable for LAB.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Growing faster than its price suggests
15.9% revenue growth
Generating 1.0B in free cash flow
Reasonable price relative to book value
Areas to Watch
Premium valuation, high expectations priced in
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -13.1% — below average capital efficiency
Revenue declined 14.2%
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on Market Cap, PEG Ratio, Revenue Growth. Revenue growth of 15.9% demonstrates continued momentum. PEG of 0.75 suggests the stock is reasonably priced for its growth.
Bull Case : LAB
The strongest argument for LAB centers on Price/Book.
Bear Case : BSX
The primary concerns for BSX are P/E Ratio.
Bear Case : LAB
The primary concerns for LAB are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
BSX profiles as a growth stock while LAB is a turnaround play — different risk/reward profiles.
LAB carries more volatility with a beta of 1.37 — expect wider price swings.
BSX is growing revenue faster at 15.9% — sustainability is the question.
BSX generates stronger free cash flow (1.0B), providing more financial flexibility.
Bottom Line
BSX scores higher overall (63/100 vs 31/100) and 15.9% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Standard Biotools Inc
HEALTHCARE · MEDICAL DEVICES · USA
Standard Biotools Inc. (LAB) is a leading biotechnology firm committed to advancing the capabilities of genomic analysis and biological research through innovative tools and technologies. The company specializes in high-performance products designed specifically for laboratories focused on genomics and proteomics, significantly improving research accuracy and efficiency. By leveraging proprietary platforms, Standard Biotools empowers scientists to accelerate their discoveries and enhance the quality of their work. With a strategic position within the dynamic biotechnology landscape, LAB is poised to meet the rising demand for sophisticated analytical solutions vital to the life sciences industry.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?